Last updated on August 2018

Prospective Outcomes Study: Vectra DA Guided Care Compared to Usual Care

Brief description of study

In this 12-month multi-center prospective, site-randomized, two-arm trial, approximately 318 biologic-nave subjects with RA who are candidates for treatment intensification due to inadequate response to MTX monotherapy will be enrolled at up to 60 study sites.

Detailed Study Description

To determine whether a strategy of Vectra DA guided care (Arm A), compared with usual care (Arm B), achieves non-inferior clinical outcomes while reducing the cost of treatment in patients with active RA and an inadequate response to MTX monotherapy.

Clinical Study Identifier: NCT02832297

Find a site near you

Start Over

Shores Rheumatology, P.C.

Saint Clair Shores, MI United States
  Connect »